Literature DB >> 302164

Persisting lymphocyte deficiences during remission in Hodgkin's disease.

M Björkholm, G Holm, H Mellstedt.   

Abstract

Blood lymphocytes from nineteen patients with Hodgkin's disease were tested in vitro before and after treatment. The patients were retested in complete and unmaintained remission at least 15 months after termination of radiotherapy. All patients except two had been treated with total nodal irradiation. The lymphocyte-DNA synthesis induced by concanavalin A (Con A) and PPD was poor and the spontaneous DNA synthesis was increased in untreated patients. Most patients had a T lymphocytopenia before treatment. After irradiation the total lymphocyte counts were reduced drastically. The number of T lymphocytes was particularly low, though the number of B lymphocytes decreased as well. However, the lymphocyte response to Con A and PPD remained low and unchanged. The results may suggest a persisting immunodeficiency in Hodgkin's disease as reflected by the lymphocyte response to Con A and PPD.

Entities:  

Mesh:

Year:  1977        PMID: 302164      PMCID: PMC1541004     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Immunodeficiency and prognosis in Hodgkin's disease.

Authors:  M Björkholm; G Holm; H Mellstedt; B Johansson
Journal:  Acta Med Scand       Date:  1975-10

2.  Studies on delayed hypersensitivity in Hodgkin's disease.

Authors:  A C AISENBERG
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

Review 3.  HODGKIN'S DISEASE--PROGNOSIS, TREATMENT AND ETIOLOGIC AND IMMUNOLOGIC CONSIDERATIONS.

Authors:  A C AISENBERG
Journal:  N Engl J Med       Date:  1964-03-05       Impact factor: 91.245

4.  An investigation of Hodgkin's disease with respect to the problem of homotransplantation.

Authors:  W D KELLY; D L LAMB; R L VARCO; R A GOOD
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

5.  Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.

Authors:  Z Fuks; S Strober; A M Bobrove; T Sasazuki; A McMichael; H S Kaplan
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

6.  Lymphopenia and metastatic breast cancer patients with and without radiation therapy.

Authors:  U Glas; J Wasserman; H Blomgren; A de Schryver
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Jan-Feb       Impact factor: 7.038

7.  Rosette formation in Hodgkin's disease.

Authors:  A Swain; J R Trounce
Journal:  Oncology       Date:  1974       Impact factor: 2.935

8.  Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis.

Authors:  M W Chase
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

9.  Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma.

Authors:  J Stjernswärd; M Jondal; F Vánky; H Wigzell; R Sealy
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

10.  Lymphocyte transformation changes during the clinical course of Hodgkin's disease.

Authors:  S M Jackson; J V Garrett; A W Craig
Journal:  Cancer       Date:  1970-04       Impact factor: 6.860

View more
  8 in total

1.  Persistent changes in circulating white blood cell populations after splenectomy.

Authors:  Minke A E Rab; Aafke Meerveld-Eggink; Heleen van Velzen-Blad; Douwe van Loon; Ger T Rijkers; Okke de Weerdt
Journal:  Int J Hematol       Date:  2017-09-26       Impact factor: 2.490

2.  Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.

Authors:  M Björkholm; G Holm; J Askergren; H Mellstedt
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

3.  Immunity in Hodgkin's disease: status after 10 years remission.

Authors:  L J Bruce; B W Hancock
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

4.  Immunity in Hodgkin's disease: status after 5 years' remission.

Authors:  B W Hancock; L Bruce; M D Whitham; I R Dunsmore; A M Ward; J Richmond
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

5.  Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.

Authors:  C Wedelin; M Björkholm; G Holm; S Ogenstad; B Johansson; H Mellstedt
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

6.  Epidemiological study of socioeconomic factors and clinical findings in Hodgkin's disease, and reanalysis of previous data regarding chemical exposure.

Authors:  L Hardell; N O Bengtsson
Journal:  Br J Cancer       Date:  1983-08       Impact factor: 7.640

7.  Prognostic effect of early diagnostic splenectomy in Hodgkin's disease: a randomized trial.

Authors:  J Askergren; M Björkholm; G Holm; B Johansson; H Mellstedt; R Sundblad; G Söderberg
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

8.  An intronic deletion in megakaryoblastic leukemia 1 is associated with hyperproliferation of B cells in triplets with Hodgkin lymphoma.

Authors:  Julien Record; Anton Sendel; Joanna S Kritikou; Nikolai V Kuznetsov; Hanna Brauner; Minghui He; Noemi Nagy; Mariana M S Oliveira; Elena Griseti; Christoph B Haase; Jenny Dahlström; Sanjaykumar Boddul; Fredrik Wermeling; Adrian J Thrasher; Chaohong Liu; John Andersson; Hans-Erik Claesson; Ola Winqvist; Siobhan O Burns; Magnus Björkholm; Lisa S Westerberg
Journal:  Haematologica       Date:  2019-10-03       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.